Cognitive and psychosocial features in childhood and juvenile MS: Two-year follow-up
To assess the evolution of cognitive and psychosocial functioning in a cohort of childhood and juvenile multiple sclerosis (MS) cases after a mean period of 2 years had elapsed since baseline evaluation. In this cohort study, we used the same extensive neuropsychological battery with alternative ver...
Gespeichert in:
Veröffentlicht in: | Neurology 2010-09, Vol.75 (13), p.1134-1140 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1140 |
---|---|
container_issue | 13 |
container_start_page | 1134 |
container_title | Neurology |
container_volume | 75 |
creator | AMATO, M. P GORETTI, B VECCHIO, R POZZILLI, C BIANCHI, V ROSCIO, M MARTINELLI, V COMI, G PORTACCIO, E TROJANO, M GHEZZI, A LORI, S ZIPOLI, V MOIOLA, L FALAUTANO, M DE CARO, M. F VITERBO, R PATTI, F |
description | To assess the evolution of cognitive and psychosocial functioning in a cohort of childhood and juvenile multiple sclerosis (MS) cases after a mean period of 2 years had elapsed since baseline evaluation.
In this cohort study, we used the same extensive neuropsychological battery with alternative versions of the tests assessing memory, attention/concentration, executive functions, and language. Fatigue and depression were also measured. An interview on school and daily living activities was obtained from the parents. The cognitive performance of the patients was compared with that of demographically matched healthy controls (HC).
Fifty-six patients and 50 HC were assessed. At follow-up, criteria for cognitive impairment (failure on at least 3 tests) were fulfilled in 39 patients (70%) and 75% of the cases were classified as having a deteriorating cognitive performance. Changes were prominent in tests of verbal memory, complex attention, verbal fluency, and receptive language. In the regression analysis, the only significant predictor of cognitive deterioration was older age of the subject (odds ratio 1.9, 95% confidence interval 1.2-2.9, p = 0.003). Psychiatric disorders, most frequently depression, were diagnosed in 12 patients (30.5%). Fatigue was reported by 21% of the patients. MS negatively affected school and everyday activities in 30% to 40% of the subjects.
Our findings confirm the importance of systematic assessment of cognitive and psychosocial issues in children and teens with MS. The progressive nature of the cognitive difficulties emphasizes the need for developing effective treatment strategies. |
doi_str_mv | 10.1212/WNL.0b013e3181f4d821 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_839706586</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>756658188</sourcerecordid><originalsourceid>FETCH-LOGICAL-c317t-61890677c24c8cacb53da60b5988b611b75958d0de42d333754bce6cc7310aed3</originalsourceid><addsrcrecordid>eNqF0LtOwzAUBmALgWgpvAFCWRBTii_xJWyo4iYVGCiCLXJsh7py42Inrfr2BFpAYmE6w_n-c6QfgGMEhwgjfP7yMB7CEiJiCBKoyrTAaAf0EcUsZQS_7oI-hFikRHDRAwcxziDsljzfBz0MBWcZ430wGfm32jZ2aRJZ62QR12rqo1dWuqQysmmDiYmtEzW1Tk-9119s1i5NbZ1J7p8uksnKp2sjQ1J55_wqbReHYK-SLpqj7RyA5-uryeg2HT_e3I0ux6kiiDcpQyKHjHOFMyWUVCUlWjJY0lyIkiFUcppToaE2GdaEEE6zUhmmFCcISqPJAJxt7i6Cf29NbIq5jco4J2vj21gIknPIqGD_Sk5Z55AQncw2UgUfYzBVsQh2LsO6QLD4LL7oii_-Ft_FTrYP2nJu9E_ou-kOnG6BjEq6Ksha2fjrCM45xoR8AIOdjDM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>756658188</pqid></control><display><type>article</type><title>Cognitive and psychosocial features in childhood and juvenile MS: Two-year follow-up</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>AMATO, M. P ; GORETTI, B ; VECCHIO, R ; POZZILLI, C ; BIANCHI, V ; ROSCIO, M ; MARTINELLI, V ; COMI, G ; PORTACCIO, E ; TROJANO, M ; GHEZZI, A ; LORI, S ; ZIPOLI, V ; MOIOLA, L ; FALAUTANO, M ; DE CARO, M. F ; VITERBO, R ; PATTI, F</creator><creatorcontrib>AMATO, M. P ; GORETTI, B ; VECCHIO, R ; POZZILLI, C ; BIANCHI, V ; ROSCIO, M ; MARTINELLI, V ; COMI, G ; PORTACCIO, E ; TROJANO, M ; GHEZZI, A ; LORI, S ; ZIPOLI, V ; MOIOLA, L ; FALAUTANO, M ; DE CARO, M. F ; VITERBO, R ; PATTI, F ; Multiple Sclerosis Study Group of the Italian Neurological Society</creatorcontrib><description>To assess the evolution of cognitive and psychosocial functioning in a cohort of childhood and juvenile multiple sclerosis (MS) cases after a mean period of 2 years had elapsed since baseline evaluation.
In this cohort study, we used the same extensive neuropsychological battery with alternative versions of the tests assessing memory, attention/concentration, executive functions, and language. Fatigue and depression were also measured. An interview on school and daily living activities was obtained from the parents. The cognitive performance of the patients was compared with that of demographically matched healthy controls (HC).
Fifty-six patients and 50 HC were assessed. At follow-up, criteria for cognitive impairment (failure on at least 3 tests) were fulfilled in 39 patients (70%) and 75% of the cases were classified as having a deteriorating cognitive performance. Changes were prominent in tests of verbal memory, complex attention, verbal fluency, and receptive language. In the regression analysis, the only significant predictor of cognitive deterioration was older age of the subject (odds ratio 1.9, 95% confidence interval 1.2-2.9, p = 0.003). Psychiatric disorders, most frequently depression, were diagnosed in 12 patients (30.5%). Fatigue was reported by 21% of the patients. MS negatively affected school and everyday activities in 30% to 40% of the subjects.
Our findings confirm the importance of systematic assessment of cognitive and psychosocial issues in children and teens with MS. The progressive nature of the cognitive difficulties emphasizes the need for developing effective treatment strategies.</description><identifier>ISSN: 0028-3878</identifier><identifier>EISSN: 1526-632X</identifier><identifier>DOI: 10.1212/WNL.0b013e3181f4d821</identifier><identifier>PMID: 20876467</identifier><identifier>CODEN: NEURAI</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Achievement ; Adolescent ; Attention - drug effects ; Attention - physiology ; Biological and medical sciences ; Case-Control Studies ; Child ; Cognition Disorders - drug therapy ; Cognition Disorders - etiology ; Cohort Studies ; Disability Evaluation ; Female ; Humans ; Immunologic Factors - therapeutic use ; Italy ; Longitudinal Studies ; Male ; Medical sciences ; Memory - drug effects ; Memory - physiology ; Multiple Sclerosis - complications ; Multiple Sclerosis - psychology ; Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis ; Neurology ; Neuropsychological Tests ; Psychology ; Statistics, Nonparametric ; Verbal Learning - drug effects ; Verbal Learning - physiology</subject><ispartof>Neurology, 2010-09, Vol.75 (13), p.1134-1140</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c317t-61890677c24c8cacb53da60b5988b611b75958d0de42d333754bce6cc7310aed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23297223$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20876467$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AMATO, M. P</creatorcontrib><creatorcontrib>GORETTI, B</creatorcontrib><creatorcontrib>VECCHIO, R</creatorcontrib><creatorcontrib>POZZILLI, C</creatorcontrib><creatorcontrib>BIANCHI, V</creatorcontrib><creatorcontrib>ROSCIO, M</creatorcontrib><creatorcontrib>MARTINELLI, V</creatorcontrib><creatorcontrib>COMI, G</creatorcontrib><creatorcontrib>PORTACCIO, E</creatorcontrib><creatorcontrib>TROJANO, M</creatorcontrib><creatorcontrib>GHEZZI, A</creatorcontrib><creatorcontrib>LORI, S</creatorcontrib><creatorcontrib>ZIPOLI, V</creatorcontrib><creatorcontrib>MOIOLA, L</creatorcontrib><creatorcontrib>FALAUTANO, M</creatorcontrib><creatorcontrib>DE CARO, M. F</creatorcontrib><creatorcontrib>VITERBO, R</creatorcontrib><creatorcontrib>PATTI, F</creatorcontrib><creatorcontrib>Multiple Sclerosis Study Group of the Italian Neurological Society</creatorcontrib><title>Cognitive and psychosocial features in childhood and juvenile MS: Two-year follow-up</title><title>Neurology</title><addtitle>Neurology</addtitle><description>To assess the evolution of cognitive and psychosocial functioning in a cohort of childhood and juvenile multiple sclerosis (MS) cases after a mean period of 2 years had elapsed since baseline evaluation.
In this cohort study, we used the same extensive neuropsychological battery with alternative versions of the tests assessing memory, attention/concentration, executive functions, and language. Fatigue and depression were also measured. An interview on school and daily living activities was obtained from the parents. The cognitive performance of the patients was compared with that of demographically matched healthy controls (HC).
Fifty-six patients and 50 HC were assessed. At follow-up, criteria for cognitive impairment (failure on at least 3 tests) were fulfilled in 39 patients (70%) and 75% of the cases were classified as having a deteriorating cognitive performance. Changes were prominent in tests of verbal memory, complex attention, verbal fluency, and receptive language. In the regression analysis, the only significant predictor of cognitive deterioration was older age of the subject (odds ratio 1.9, 95% confidence interval 1.2-2.9, p = 0.003). Psychiatric disorders, most frequently depression, were diagnosed in 12 patients (30.5%). Fatigue was reported by 21% of the patients. MS negatively affected school and everyday activities in 30% to 40% of the subjects.
Our findings confirm the importance of systematic assessment of cognitive and psychosocial issues in children and teens with MS. The progressive nature of the cognitive difficulties emphasizes the need for developing effective treatment strategies.</description><subject>Achievement</subject><subject>Adolescent</subject><subject>Attention - drug effects</subject><subject>Attention - physiology</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>Child</subject><subject>Cognition Disorders - drug therapy</subject><subject>Cognition Disorders - etiology</subject><subject>Cohort Studies</subject><subject>Disability Evaluation</subject><subject>Female</subject><subject>Humans</subject><subject>Immunologic Factors - therapeutic use</subject><subject>Italy</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Memory - drug effects</subject><subject>Memory - physiology</subject><subject>Multiple Sclerosis - complications</subject><subject>Multiple Sclerosis - psychology</subject><subject>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</subject><subject>Neurology</subject><subject>Neuropsychological Tests</subject><subject>Psychology</subject><subject>Statistics, Nonparametric</subject><subject>Verbal Learning - drug effects</subject><subject>Verbal Learning - physiology</subject><issn>0028-3878</issn><issn>1526-632X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0LtOwzAUBmALgWgpvAFCWRBTii_xJWyo4iYVGCiCLXJsh7py42Inrfr2BFpAYmE6w_n-c6QfgGMEhwgjfP7yMB7CEiJiCBKoyrTAaAf0EcUsZQS_7oI-hFikRHDRAwcxziDsljzfBz0MBWcZ430wGfm32jZ2aRJZ62QR12rqo1dWuqQysmmDiYmtEzW1Tk-9119s1i5NbZ1J7p8uksnKp2sjQ1J55_wqbReHYK-SLpqj7RyA5-uryeg2HT_e3I0ux6kiiDcpQyKHjHOFMyWUVCUlWjJY0lyIkiFUcppToaE2GdaEEE6zUhmmFCcISqPJAJxt7i6Cf29NbIq5jco4J2vj21gIknPIqGD_Sk5Z55AQncw2UgUfYzBVsQh2LsO6QLD4LL7oii_-Ft_FTrYP2nJu9E_ou-kOnG6BjEq6Ksha2fjrCM45xoR8AIOdjDM</recordid><startdate>20100928</startdate><enddate>20100928</enddate><creator>AMATO, M. P</creator><creator>GORETTI, B</creator><creator>VECCHIO, R</creator><creator>POZZILLI, C</creator><creator>BIANCHI, V</creator><creator>ROSCIO, M</creator><creator>MARTINELLI, V</creator><creator>COMI, G</creator><creator>PORTACCIO, E</creator><creator>TROJANO, M</creator><creator>GHEZZI, A</creator><creator>LORI, S</creator><creator>ZIPOLI, V</creator><creator>MOIOLA, L</creator><creator>FALAUTANO, M</creator><creator>DE CARO, M. F</creator><creator>VITERBO, R</creator><creator>PATTI, F</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20100928</creationdate><title>Cognitive and psychosocial features in childhood and juvenile MS: Two-year follow-up</title><author>AMATO, M. P ; GORETTI, B ; VECCHIO, R ; POZZILLI, C ; BIANCHI, V ; ROSCIO, M ; MARTINELLI, V ; COMI, G ; PORTACCIO, E ; TROJANO, M ; GHEZZI, A ; LORI, S ; ZIPOLI, V ; MOIOLA, L ; FALAUTANO, M ; DE CARO, M. F ; VITERBO, R ; PATTI, F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c317t-61890677c24c8cacb53da60b5988b611b75958d0de42d333754bce6cc7310aed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Achievement</topic><topic>Adolescent</topic><topic>Attention - drug effects</topic><topic>Attention - physiology</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>Child</topic><topic>Cognition Disorders - drug therapy</topic><topic>Cognition Disorders - etiology</topic><topic>Cohort Studies</topic><topic>Disability Evaluation</topic><topic>Female</topic><topic>Humans</topic><topic>Immunologic Factors - therapeutic use</topic><topic>Italy</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Memory - drug effects</topic><topic>Memory - physiology</topic><topic>Multiple Sclerosis - complications</topic><topic>Multiple Sclerosis - psychology</topic><topic>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</topic><topic>Neurology</topic><topic>Neuropsychological Tests</topic><topic>Psychology</topic><topic>Statistics, Nonparametric</topic><topic>Verbal Learning - drug effects</topic><topic>Verbal Learning - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AMATO, M. P</creatorcontrib><creatorcontrib>GORETTI, B</creatorcontrib><creatorcontrib>VECCHIO, R</creatorcontrib><creatorcontrib>POZZILLI, C</creatorcontrib><creatorcontrib>BIANCHI, V</creatorcontrib><creatorcontrib>ROSCIO, M</creatorcontrib><creatorcontrib>MARTINELLI, V</creatorcontrib><creatorcontrib>COMI, G</creatorcontrib><creatorcontrib>PORTACCIO, E</creatorcontrib><creatorcontrib>TROJANO, M</creatorcontrib><creatorcontrib>GHEZZI, A</creatorcontrib><creatorcontrib>LORI, S</creatorcontrib><creatorcontrib>ZIPOLI, V</creatorcontrib><creatorcontrib>MOIOLA, L</creatorcontrib><creatorcontrib>FALAUTANO, M</creatorcontrib><creatorcontrib>DE CARO, M. F</creatorcontrib><creatorcontrib>VITERBO, R</creatorcontrib><creatorcontrib>PATTI, F</creatorcontrib><creatorcontrib>Multiple Sclerosis Study Group of the Italian Neurological Society</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AMATO, M. P</au><au>GORETTI, B</au><au>VECCHIO, R</au><au>POZZILLI, C</au><au>BIANCHI, V</au><au>ROSCIO, M</au><au>MARTINELLI, V</au><au>COMI, G</au><au>PORTACCIO, E</au><au>TROJANO, M</au><au>GHEZZI, A</au><au>LORI, S</au><au>ZIPOLI, V</au><au>MOIOLA, L</au><au>FALAUTANO, M</au><au>DE CARO, M. F</au><au>VITERBO, R</au><au>PATTI, F</au><aucorp>Multiple Sclerosis Study Group of the Italian Neurological Society</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cognitive and psychosocial features in childhood and juvenile MS: Two-year follow-up</atitle><jtitle>Neurology</jtitle><addtitle>Neurology</addtitle><date>2010-09-28</date><risdate>2010</risdate><volume>75</volume><issue>13</issue><spage>1134</spage><epage>1140</epage><pages>1134-1140</pages><issn>0028-3878</issn><eissn>1526-632X</eissn><coden>NEURAI</coden><abstract>To assess the evolution of cognitive and psychosocial functioning in a cohort of childhood and juvenile multiple sclerosis (MS) cases after a mean period of 2 years had elapsed since baseline evaluation.
In this cohort study, we used the same extensive neuropsychological battery with alternative versions of the tests assessing memory, attention/concentration, executive functions, and language. Fatigue and depression were also measured. An interview on school and daily living activities was obtained from the parents. The cognitive performance of the patients was compared with that of demographically matched healthy controls (HC).
Fifty-six patients and 50 HC were assessed. At follow-up, criteria for cognitive impairment (failure on at least 3 tests) were fulfilled in 39 patients (70%) and 75% of the cases were classified as having a deteriorating cognitive performance. Changes were prominent in tests of verbal memory, complex attention, verbal fluency, and receptive language. In the regression analysis, the only significant predictor of cognitive deterioration was older age of the subject (odds ratio 1.9, 95% confidence interval 1.2-2.9, p = 0.003). Psychiatric disorders, most frequently depression, were diagnosed in 12 patients (30.5%). Fatigue was reported by 21% of the patients. MS negatively affected school and everyday activities in 30% to 40% of the subjects.
Our findings confirm the importance of systematic assessment of cognitive and psychosocial issues in children and teens with MS. The progressive nature of the cognitive difficulties emphasizes the need for developing effective treatment strategies.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>20876467</pmid><doi>10.1212/WNL.0b013e3181f4d821</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-3878 |
ispartof | Neurology, 2010-09, Vol.75 (13), p.1134-1140 |
issn | 0028-3878 1526-632X |
language | eng |
recordid | cdi_proquest_miscellaneous_839706586 |
source | MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection |
subjects | Achievement Adolescent Attention - drug effects Attention - physiology Biological and medical sciences Case-Control Studies Child Cognition Disorders - drug therapy Cognition Disorders - etiology Cohort Studies Disability Evaluation Female Humans Immunologic Factors - therapeutic use Italy Longitudinal Studies Male Medical sciences Memory - drug effects Memory - physiology Multiple Sclerosis - complications Multiple Sclerosis - psychology Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Neurology Neuropsychological Tests Psychology Statistics, Nonparametric Verbal Learning - drug effects Verbal Learning - physiology |
title | Cognitive and psychosocial features in childhood and juvenile MS: Two-year follow-up |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T15%3A53%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cognitive%20and%20psychosocial%20features%20in%20childhood%20and%20juvenile%20MS:%20Two-year%20follow-up&rft.jtitle=Neurology&rft.au=AMATO,%20M.%20P&rft.aucorp=Multiple%20Sclerosis%20Study%20Group%20of%20the%20Italian%20Neurological%20Society&rft.date=2010-09-28&rft.volume=75&rft.issue=13&rft.spage=1134&rft.epage=1140&rft.pages=1134-1140&rft.issn=0028-3878&rft.eissn=1526-632X&rft.coden=NEURAI&rft_id=info:doi/10.1212/WNL.0b013e3181f4d821&rft_dat=%3Cproquest_cross%3E756658188%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=756658188&rft_id=info:pmid/20876467&rfr_iscdi=true |